Cargando…

Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas

Detalles Bibliográficos
Autores principales:	Wang, Justin Z., Patil, Vikas, Liu, Jeff, Dogan, Helin, Tabatabai, Ghazaleh, Yefet, Leeor S., Behling, Felix, Hoffman, Elgin, Bunda, Severa, Yakubov, Rebecca, Kaloti, Ramneet, Brandner, Sebastian, Gao, Andrew, Cohen-Gadol, Aaron, Barnholtz-Sloan, Jill, Skardelly, Marco, Tatagiba, Marcos, Raleigh, David R., Sahm, Felix, Boutros, Paul C., Aldape, Kenneth, Nassiri, Farshad, Zadeh, Gelareh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261159/ https://www.ncbi.nlm.nih.gov/pubmed/37171636 http://dx.doi.org/10.1007/s00401-023-02584-y

Ejemplares similares

Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
por: Wang, Justin Z., et al.
Publicado: (2023)

COMPREHENSIVE MULTIPLATFORM ANALYSIS OF CDKN2A ALTERATIONS IN MENINGIOMAS
por: Wang, Justin Z, et al.
Publicado: (2023)

The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy
por: Behling, Felix, et al.
Publicado: (2020)

Increased proliferation is associated with CNS invasion in meningiomas
por: Behling, Felix, et al.
Publicado: (2021)

Correction to: The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma
por: Fodi, Christina, et al.
Publicado: (2022)

The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma
por: Fodi, Christina, et al.
Publicado: (2021)

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
por: Behling, Felix, et al.
Publicado: (2018)

The prognostic role of the immunohistochemical expression of S100 in meningiomas
por: Behling, Felix, et al.
Publicado: (2022)

Loss of H3K27me3 in meningiomas: an independent marker for CNS WHO grade 2?
por: Behling, Felix, et al.
Publicado: (2023)

Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort
por: Gonçalves, Vítor Moura, et al.
Publicado: (2021)

Differences in the expression of SSTR1–5 in meningiomas and its therapeutic potential
por: Behling, Felix, et al.
Publicado: (2021)

Correction: Gonçalves et al. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. Cancers 2021, 13, 466
por: Gonçalves, Vítor Moura, et al.
Publicado: (2023)

COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake
por: Behling, Felix, et al.
Publicado: (2019)

CNS Invasion in Meningioma—How the Intraoperative Assessment Can Improve the Prognostic Evaluation of Tumor Recurrence
por: Behling, Felix, et al.
Publicado: (2020)

H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort
por: Behling, Felix, et al.
Publicado: (2020)

COX2 expression is associated with preoperative tumor volume but not with volumetric tumor growth in vestibular schwannoma
por: Behling, Felix, et al.
Publicado: (2021)

Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy
por: Hoffmann, Elgin, et al.
Publicado: (2021)

A Continuous Correlation Between Residual Tumor Volume and Survival Recommends Maximal Safe Resection in Glioblastoma Patients: A Nomogram for Clinical Decision Making and Reference for Non-Randomized Trials
por: Skardelly, Marco, et al.
Publicado: (2021)

Integrative assessment of brain and bone invasion in meningioma patients
por: Zwirner, Kerstin, et al.
Publicado: (2019)

Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status
por: Karimi, Shirin, et al.
Publicado: (2021)

Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors
por: Bunda, Severa, et al.
Publicado: (2021)

Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors
por: Engelhardt, Sophie, et al.
Publicado: (2022)

TNFα secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy
por: Wei, Qingxia, et al.
Publicado: (2021)

SHH PATHWAY ACTIVATION DRIVES MALIGNANT TRANSFORMATION IN A SUBSET OF MPNSTS AND IS A POTENTIAL THERAPEUTIC TARGET
por: Suppiah, Suganth, et al.
Publicado: (2023)

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
por: Behling, Felix, et al.
Publicado: (2016)

JAK/STAT PATHWAY COOPERATES WITH CIC FUSIONS TO DRIVE CIC-REARRANGED SARCOMAS
por: Kaloti, R K, et al.
Publicado: (2023)

Introduction: Ongoing clinical challenges in the management of meningiomas and future directions
por: Wang, Justin Z, et al.
Publicado: (2023)

Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology, and treatment
por: Trautwein, Christoph, et al.
Publicado: (2022)

DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology
por: Pratt, Drew, et al.
Publicado: (2021)

ADC-Based Stratification of Molecular Glioma Subtypes Using High b-Value Diffusion-Weighted Imaging
por: Nuessle, Nils C., et al.
Publicado: (2021)

SOCS-1 Mediates Ubiquitylation and Degradation of GM-CSF Receptor
por: Bunda, Severa, et al.
Publicado: (2013)

Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
por: Bunda, Severa, et al.
Publicado: (2015)

Glioma-Specific Diffusion Signature in Diffusion Kurtosis Imaging
por: Hempel, Johann-Martin, et al.
Publicado: (2021)

SHH PATHWAY ACTIVATION IN DEDIFFERENTIATION DURING TUMOR PROGRESSION IN MPNST
por: Yakubov, R Y, et al.
Publicado: (2023)

ATRX immunostaining predicts IDH and H3F3A status in gliomas
por: Ebrahimi, Azadeh, et al.
Publicado: (2016)

One-on-one mentoring for final year medical students during the neurosurgery rotation
por: Behling, Felix, et al.
Publicado: (2021)

Correction to: Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes
por: Brendle, Cornelia, et al.
Publicado: (2021)

Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes
por: Brendle, Cornelia, et al.
Publicado: (2020)

Complete and Incomplete Resection for Progressive Glioblastoma Prolongs Post-Progression Survival
por: Behling, Felix, et al.
Publicado: (2022)

Transition of a vestibular schwannoma to a malignant peripheral nerve sheath tumor with loss of H3K27 trimethylation after radiosurgery—a case report and review of the literature
por: Behling, Felix, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gitndk3h9gnibjhiu0v8ijf0cl